Stomatodynia is a difficult disease for both patients and clinicians.
When facing true stomatodynia, ie, idiopathic burning mouth, patients
are offered poorly effective treatment. This open study reports the re
sults of local application of clonazepam (0.5 or 1 mg) two or three ti
mes daily in 25 subjects who suffered from idiopathic stomatodynia. At
the first evaluation, 4 weeks after the beginning of treatment, a vis
ual analogue scale (VAS) that represented the intensity of pain decrea
sed significantly from 6.2 +/- 0.3 to 3.0 +/- 0.5. At the second evalu
ation, 3 to 29 months after the first consultation, the VAS scores dro
pped significantly further to 2.6 +/- 0.5. Analysis of the individual
results showed that 10 patients were totally cured and needed no furth
er treatment, 6 patients had no benefit at all, and the remaining 9 pa
tients had some improvement but were not considered to be cured since
they did not wish to stop the treatment. Blood level tests that were p
erformed 1 and 3 hours after the topical application revealed the pres
ence of small amounts of the drug (3.3 ng/mL +/- 0.66 and 3.3 ng/mL +/
- 0.52, respectively). The hypothesis that clonazepam acts locally to
disrupt the neuropathologic mechanism that underlies stomatodynia is p
roposed. The risk factors that are recognized for this condition could
decrease the density and/or ligand affinity of peripheral benzodiazep
ine receptors. This, in turn, could cause spontaneous pain from the ti
ssues concerned.